William Resides
Vermögen: 144 719 $ am 31.07.2026
Vermögen: 144 719 $ am 31.07.2026
Mr. William Resides is a Director, Chief Executive & Financial Officer at BioRegenx, Inc. and a Managing Member at Resides Enterprises, LLC.
He is on the Board of Directors at BioRegenx, Inc. Mr. Resides was previously employed as a Chief Executive Officer by NuLife Sciences, Inc., a Chief Executive Officer by AllTech Systems, Inc., a Chief Executive Officer & Director by BioRegenx, Inc. /Old/, a Vice President-Business Development by Loop Media, Inc., and a Managing Member by Nulife Ventures LLC.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BIOREGENX INC 2,13 % | 15.04.2025 | 20 674 000 ( 2,13 % ) | 144 718 $ | 31.07.2026 |
FINDIT INC PFD A 2,95 % | 15.04.2025 | 112 ( 2,95 % ) | 1 $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOREGENX, INC. | Vorstandsvorsitzender | 08.03.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
AllTech Systems, Inc.
AllTech Systems, Inc. Miscellaneous Commercial ServicesCommercial Services Provides consulting services for data processing industry | Vorstandsvorsitzender | - |
| LOOP MEDIA, INC. | Corporate Officer/Principal | - |
NuLife Sciences, Inc.
NuLife Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides online market and community connecting services | Vorstandsvorsitzender | - |
Nulife Ventures LLC
Nulife Ventures LLC Aerospace & DefenseElectronic Technology Nulife Ventures LLC, operating as Nulife Sciences, is a health-focused company specializing in advancing vascular, microcirculation, and overall wellness through scientifically supported products and technologies. The company is based in Chattanooga, TN. The company offers the GlycoCheck system, a research-grade device for licensed medical professionals to assess microvascular health, aiding in monitoring conditions linked to vascular dysfunction such as diabetes, hypertension, heart and kidney diseases, stroke, dementia, and inflammatory disorders. Nulife Sciences develops and markets dietary supplements under the MyBodyRx line, including Endocalyx Pro, a patented formula designed to repair and maintain the endothelial glycocalyx, as well as other supplements targeting brain, gut, muscle, and emotional health. The company's products incorporate bioactive compounds and are supported by scientific research and clinical studies. The company also provides health technologies such as PEMF and EMS therapy devices, and Echo hydrogen water machines for cognitive enhancement, oxidative stress reduction, and immune support. Nulife Sciences combines supplementation, lifestyle, and innovative therapies to promote wellness and offers research resources and collaborations with health practitioners. | Corporate Officer/Principal | - |
BioRegenx, Inc.
BioRegenx, Inc. Pharmaceuticals: OtherHealth Technology Operates as a holding company with interest in research & development, sale and marketing of dietary supplements | Gründer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
NuLife Sciences, Inc.
NuLife Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides online market and community connecting services | Commercial Services |
AllTech Systems, Inc.
AllTech Systems, Inc. Miscellaneous Commercial ServicesCommercial Services Provides consulting services for data processing industry | Commercial Services |
BioRegenx, Inc.
BioRegenx, Inc. Information Technology ServicesTechnology Services Develops social media content management platform | Technology Services |
Loop Media, Inc.
Loop Media, Inc. Internet Software/ServicesTechnology Services Operates an app which provides live streaming music video channels | Technology Services |
BioRegenx, Inc.
BioRegenx, Inc. Pharmaceuticals: OtherHealth Technology Operates as a holding company with interest in research & development, sale and marketing of dietary supplements | Health Technology |
Nulife Ventures LLC
Nulife Ventures LLC Aerospace & DefenseElectronic Technology Nulife Ventures LLC, operating as Nulife Sciences, is a health-focused company specializing in advancing vascular, microcirculation, and overall wellness through scientifically supported products and technologies. The company is based in Chattanooga, TN. The company offers the GlycoCheck system, a research-grade device for licensed medical professionals to assess microvascular health, aiding in monitoring conditions linked to vascular dysfunction such as diabetes, hypertension, heart and kidney diseases, stroke, dementia, and inflammatory disorders. Nulife Sciences develops and markets dietary supplements under the MyBodyRx line, including Endocalyx Pro, a patented formula designed to repair and maintain the endothelial glycocalyx, as well as other supplements targeting brain, gut, muscle, and emotional health. The company's products incorporate bioactive compounds and are supported by scientific research and clinical studies. The company also provides health technologies such as PEMF and EMS therapy devices, and Echo hydrogen water machines for cognitive enhancement, oxidative stress reduction, and immune support. Nulife Sciences combines supplementation, lifestyle, and innovative therapies to promote wellness and offers research resources and collaborations with health practitioners. | Electronic Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen